Clostridium Difficile News and Research

RSS
Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.
ViroPharma initiates Phase 2 clinical study to evaluate Cinryze

ViroPharma initiates Phase 2 clinical study to evaluate Cinryze

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

EMA accepts MAA filing of ViroPharma's Cinryze for HAE

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

Infections from Clostridium difficile on the rise in community hospitals

Infections from Clostridium difficile on the rise in community hospitals

Meridian Bioscience seeks FDA marketing clearance for illumigene C. difficile molecular diagnostic test

Meridian Bioscience seeks FDA marketing clearance for illumigene C. difficile molecular diagnostic test

SHEA, IDSA release new clinical practice guidelines for CDI in adults

SHEA, IDSA release new clinical practice guidelines for CDI in adults

HAIs in southeast U.S. community hospitals: Infection rates for CDI surpass MRSA's

HAIs in southeast U.S. community hospitals: Infection rates for CDI surpass MRSA's

Bleach solution effective in reducing hospital-acquired infections

Bleach solution effective in reducing hospital-acquired infections

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

ViroPharma to present Cinryze data at Southern European Allergy Society congress

ViroPharma to present Cinryze data at Southern European Allergy Society congress

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

CDIs are becoming significant issue in healthcare institutions: Study

CDIs are becoming significant issue in healthcare institutions: Study

Kettering Health Network licenses DIATHERIX Laboratories' TEM-PCR testing process

Kettering Health Network licenses DIATHERIX Laboratories' TEM-PCR testing process

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

ViroPharma reports 76% growth in fourth-quarter net product sales

ViroPharma reports 76% growth in fourth-quarter net product sales

Excelimmune receives $1M investment as part of open Series-B financing round

Excelimmune receives $1M investment as part of open Series-B financing round

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Top-line results from Optimer Pharmaceuticals' second fidaxomicin Phase 3 trial in CDI patients

Top-line results from Optimer Pharmaceuticals' second fidaxomicin Phase 3 trial in CDI patients

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

Staying in a multi-bed hospital room increases the risk of acquiring serious infectious diseases

Staying in a multi-bed hospital room increases the risk of acquiring serious infectious diseases